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Background: Malaria is a leading cause of mortality in southern Benin. The main causative agent, Plasmodium
falciparum, poses a threat on critical transfusions in pregnant women and children. This study’s objective was to compare
the performance of different malaria screening methods in blood donors in southern Benin, a malaria-endemic country.
Methods: Blood from 2,515 voluntary blood donors in Benin was collected over a period of 10 months in
ethylenediaminetetraacetic acid (EDTA) tubes, which were then classified according to extraction time: long rainy season,
short dry season, short rainy season, and long dry season. Microscopic examination was used to count parasites. Parasite
density (PD) was expressed as the number of parasites per μL of blood. Pan Plasmodium pLDH detection was assessed
by an ELISA-malaria antigen test. Using crude soluble P. falciparum antigens, an ELISA-malaria antibody test detected
anti-Plasmodium antibodies.
Results: Among the 2,515 blood donors (2,025 males and 488 females) screened, the rate of asymptomatic Plasmodium
carriage was 295/2,515 (11.72%, 95% CI: 10.5-13.1%). Males had a higher infection rate (12.4%) than did females (8.8%).
Parasite density was very low: between seven and100 parasites per μL of blood was reported in 80% of donors with
parasitaemia. Three Plasmodium species were diagnosed: P. falciparum in 280/295 patients (95.0%), Plasmodium malariae
in 14/295 (5.0%), and Plasmodium ovale in 1/295 (0.34%). Malaria prevalence in donors was higher during the rainy
seasons (13.7%) compared with the dry seasons (9.9%). The use of a highly sensitive assay enabled pan Plasmodium
pLDH detection in 966/2,515 (38.4%, 95% CI: 36.5%-40.3%). Malaria antibody prevalence was 1,859/2,515 (73.9%, 95% CI:
72.16-75.6%). Donors’ antigenaemia and antibody levels varied significantly (P <0.05) over the course of the four seasons.
The highest antigenaemia rate 323/630 (51.3%), was observed during the short rainy season, while the highest antibody
prevalence, 751/886 (84.7%), was recorded during the long dry season.
Conclusion: Blood donations infected with Plasmodium can transmit malaria to donation recipients. Malaria diagnostic
methods are currently available, but the feasibility criteria for mass screening in endemic areas become preponderant.
Detection of the pLDH antigen seems to be an adequate screening tool in endemic areas, for this antigen indicates
parasite presence. Routine screening of all donated blood would prevent infected blood donations and reduce
P. falciparum transmission in critical patients, such as children and pregnant women. This tool would also decrease
medical prophylaxis in donation recipients and contribute to lower Plasmodium resistance.
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Transfusion-induced malaria was first reported in 1911
[1], and it is well-established that all five human malaria
parasites (Plasmodium falciparum, Plasmodium malariae,
Plasmodium vivax, Plasmodium ovale, and Plasmodium
knowlesi) may be transmitted via blood transfusion [2].
Blood is mainly used in the emergency management of pa-
tients with life-threatening anaemia accompanied by se-
vere malaria and malnutrition [3]. Blood transmission of
malaria is a potentially serious complication that poses a
continuous risk for blood banks, as the recipient’s malaria
diagnosis is not expected, and is thus often missed [3,4].
As malaria parasites can survive in red blood cells at re-
frigerator temperature (2-4°C) for days or weeks [5], this
would require the exclusion of all blood donors with a po-
tential risk [6,7]. Transfusion-transmitted malaria (TTM)
is an important public health problem that affects most
parts of the world. Over the past decade, TTM has been
reported in low endemic countries, such as France [8],
Brazil [9], the USA [10], and the UK [11]. The situation is
more alarming in highly endemic areas, such as sub-
Saharan Africa, where Plasmodium prevalence among
blood donors may reach record levels of 51.50% [12,13]
using a technique less sensitive than microscopy [14].
In Benin, as in other tropical developing countries, the
high demand for blood donations due to increased road
accidents, pregnancy-related haemorrhages and child an-
aemia enhances the risk of TTM. Benin’s humid tropical
climate, which has two rainy and two dry seasons, fa-
vours malaria transmission over the course of eight
months, with 58 infectious mosquito bites per man per
year [15]. The most effective malaria vector, Anopheles
gambiae, is the most widespread and difficult to control
[16]. The majority of malaria-related deaths in Benin is
caused by the lethal P. falciparum. In Benin, 37% of
adult health facility visits and 41% of those by children
under five years old are malaria-related. Malaria is the
leading disease affecting communities, with pregnant
women and children under five years old being the most
vulnerable. The incidence of uncomplicated and severe
malaria was 139 per 1,000 inhabitants in 2006 [17]. Self-
medication for malaria prevention is likely to complicate
these figures: although widespread in Benin, it has never
been objectively assessed. TTM is not considered a pri-
ority in malaria-endemic countries, but malaria preva-
lence is nonetheless decreasing thanks to the Roll Back
Malaria programme [18]. The significant risk of Plasmo-
dium transfusion is expected to increase over the next
few years in unprotected patients, such as pregnant
women or children. Blood transfusion is the third trans-
mission path of Plasmodium, and there is still no con-
sensus on TTM preventative measures to be taken in
tropical settings [19]. Malaria symptoms may be subtle
or non-existent in many blood donors carryingPlasmodium [7], so screening questionnaires have limi-
tations [20]. Moreover, routine malaria diagnosis is made
by microscopic visualization of parasites on thick and
thin smears, but this method is inadequate for examin-
ing a large volume of samples [14,20]. Nevertheless, mi-
croscopy is still commonly used in studies investigating
malaria prevalence in blood donors [13,21-23]. The use
of malaria antibody detection, as in non-endemic coun-
tries, is inadequate due the frequent high seroprevalence
in endemic countries. As previously suggested, malaria
antigen detection may be a feasible solution [7,19]. There-
fore, this study’s objective was to assess the performance
of a commercially available pLDH antigen detection
ELISA-based assay compared to microscopy in 2,515 vol-
untary blood donors who were asymptomatic for malaria.
Malaria antibody prevalence was also assessed.
Methods
Study sites and ethical consideration
Benin is characterized by tropical rainforest vegetation,
Sudanese climate type with an annual rainfall of about
1,600 mm, and an atmospheric temperature of 32°C.
There are four distinct seasons: two rainy and two dry.
This descriptive, transversal study was conducted in
Benin over ten consecutive months in six departments,
which grouped into three pairs of Departmental Blood
Transfusion Centres (DBTC): Atlantique-Littoral,Oueme-
Plateau, and Mono-Couffo. They serve as referral centres
for south Benin blood transfusion services. This study was
approved by the Direction of Benin National Blood Trans-
fusion Agency and the Research Ethics Committee of the
Republic of Benin. Approval was granted under the fol-
lowing conditions: donor anonymity must be maintained,
good laboratory practice quality control must be ensured,
and every finding must be treated with utmost confidenti-
ality and used only for this research purpose. Biological
analyses of the samples were performed in the biochemis-
try and molecular biology laboratory in Cotonou (Benin)
and the Institut de Parasitologie et de Pathologie Tropicale
de Strasbourg (IPPTS) (France).
Study population
Individuals considered healthy who visited the three
DBTCs for blood donation between May 2009 and
March 2010 were considered eligible for the study. A
total of 2,515 donors and regular voluntary blood donors
were enrolled over a period of ten months, which was
divided into a long rainy season (LRS) from May to July,
a short dry season (SDS) from August to September, a
short rainy season (SRS) from October to November,
and a long dry season (LDS) from December to March.
Donors were selected according to medical screening
criteria: no fever, no clinical evidence of progressive dis-
ease, weight above 50 kg, age between 18 and 60 years
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tion had to have occurred within the previous four
months for women and three months for men. A more
systematic questionnaire was introduced providing the
full name, age, sex, address, and telephone of each indi-
vidual. Malaria-related questions were also included:
date and confirmation via clinical manifestation of mal-
aria episodes that occurred during the year, subsequent
treatment and prevention measures taken against mal-
aria. Each study participant signed an informed consent.
Overall, 7 mL of blood were collected in EDTA tubes,
with 1 mL transferred into a microtube and the remaining
6 mL centrifuged at 4°C, plasma being collected into a
new microtube. The tubes were stored at −20°C and
transported to the IPPTS laboratory in solid carbon diox-
ide for antibody and pLDH antigen detection.
Parasitological examination
A thick and a thin smear were performed on slides for
each Benin blood donor. The thick film was dehaemog-
lobinized using distilled water at pH 7.2, and then thick
and thin blood films were stained using a May-Grünwald-
Giemsa (MGG) stain. The microscopic reading and
parasite density calculation were performed by two la-
boratory technicians, and in the case of uncertainty, also
by a third one. Parasite count was made on the basis of
500 parasites per 1,000 leukocytes. The reading was
stopped after 500 parasites were counted, even though
the 1,000 figures of leukocytes were not reached. Para-
site density (PD) was expressed as the number of para-
sites per μL of blood.
pLDH antigen detection
pLDH is a glycolytic pathway enzyme secreted by the
different Plasmodium species, but it possesses species-
specific isomers [24]. The pLDH enzyme disappears
within 24 hours of effective malaria treatment [25].
Therefore, the pLDH antigen is considered a specific
marker for the presence of viable Plasmodium in blood,
and is used for screening in malaria-endemic countries.
The pLDH antigen detection was performed by a sand-
wich enzyme-linked immunosorbent assay (ELISA), not-
ably an ELISA-malaria antigen test (apDianv, Belgium)
that detects pLDH via immunocapture. The apDia Anti-
gen ELISA is an in vitro diagnostic immunoassay (IVD)
for the qualitative determination of Plasmodium spp.
LDH in blood samples. The apDia Malaria antigen test
can be used in order to detect the malaria pLDH antigen
of any of the four species in blood samples. The test was
performed according to manufacturer recommendations:
pour 100 μL of ready-to-use lysing buffer into each well;
add 50 μL of reconstituted positive control to one well
and 50 μL of negative control to triplicate well; add 50
μL of homogenized fresh whole blood sample intocorresponding well; incubate for 60 min at 37°C under
continuous gentle shaking conditions; drain the wells via
aspiration, and fill them completely with 350 μL of
washing solution; allow the wells to soak for 1 min be-
fore washing again five times; pour 100 μL of conjugate
1 solution into each well, and incubate the plate for 30
min at 37°C; wash the wells five times and pour 100 μL
of conjugate 2 into each wells. Incubate the plate for 15
min then wash the wells five times and pour 100 μL of
chromogenic solution into each well; incubate the plate
for 15 min at 37°C; add 50 μL of stopping solution to all
wells and read absorbance of each well at 450 nm with
reference wavelength of 620 nm within 15 min. Test re-
sults were interpreted as follows: the optical densities of
positive control (ODpos) must be >0.500 and the aver-
age OD of negative control (ODneg) <0.100. The ODneg
was used to calculate the cut-off by multiplying its aver-
age value by three. The antigen index (Ag Index) of each
sample was calculated by dividing the OD value of the
sample by the cut-off value. A sample was considered
positive if the Ag Index was ≥1.0, indicating that the
sample contained viable parasites. A sample was consid-
ered negative if the Ag Index was ≤0.8, indicating that
there were no viable parasites in the blood, or that there
was no Plasmodium multiplication because of anti-
malarial drug intake. A sample was considered inconclu-
sive if the Ag Index was between 0.8 and 1.
Measurement of sensitivity, specificity and detectability
of the ELISA-based pLDH detection assay
Samples from malaria patients for sensitivity calculation
The whole blood biobank collected from 266 malaria pa-
tients who had returned from endemic countries, posi-
tively diagnosed and referred by Strasbourg University
hospital was tested. Among them, 239 were positive for
P. falciparum, 19 for P. ovale, six for P. malariae, and two
exhibited a mixed infection (P. ovale and P. falciparum).
This panel was used to assess the sensitivity of the ELISA
antigen detection test compared to microscopy.
Samples from blood donors for specificity calculation
Blood donor samples were collected at the French
Etablissement Français du Sang d’Alsace (EFS Alsace).
Based on a medical questionnaire, donors were classified
as “malaria-risk blood donors” (n=1,771) if they had trav-
elled to an endemic area in the previous four months, or
“not-exposed-to-malaria blood donors” (n=1,781) if they
had not travelled to an endemic area in the previous three
years.
Cultured parasites
The 3D7 strain of P. falciparum was maintained in vitro
using an adapted candle jar method for continuous cul-
ture [26]. Parasites were cultured in normal O-positive
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and malaria culture medium (MCM, pH 7.4) composed
of Roswell Park Memorial Institute medium (RPMI)
1640 supplemented with 2 mM L-glutamine, 10 mM
Hepes (Gibco, Invitrogen, Cergy Pontoise, France), 1 μg/
ml hypoxanthine, 0.11 mg/ml Na pyruvate, 0.02 mg/ml
gentamycin, and 10% (V/V) alpha calf serum (Perbio
Science, Brebières, France). The culture was diluted at a
parasitaemia and haematocrit of 1%, and the medium
was changed every 48 hours.
Determination of parasite detectability threshold using
microscopy and pLDH Elisa test
Culture with 65% ring-stage parasites and 35% schizonts
was used. Infected RBCs from the continuous culture at
1% parasitaemia determined on thin blood film by mi-
croscopy were serially diluted in uninfected RBCs by in-
cubation with low agitation at 37°C. Dilution ranged
from 20,000 infected RBCs (iRBCs)/μl to 0.1 iRBCs/μl.
For microscopy examination, thin blood films were
made from each dilution after careful suspension, while
thick blood films were made for the lower parasitaemia.
Three slides were prepared for each dilution and read by
two microscopists in a blind manner. Parasitaemia was
determined by counting fields with 100 RBCs, and the
total level was expressed in μL of blood corresponding
of 5.106 RBCs/μL. A linear regression curve based on
mean parasitaemia levels was established in order to deter-
mine the parasitaemia, and a standard curve was gener-
ated using recombinant pLDH to assess the correlation
between parasitaemia and pLDH concentration.
Recombinant pLDH
A synthetic gene (Genscript, NJ, USA) encoding for P.
falciparum pLDH protein was inserted in the expression
vector pMAL C2X (New England Biolabs, Ipswich, MA,
USA) containing the maltose binding protein (MBP) fu-
sion partner sequence. The protein was expressed in
Escherichia coli and purified by affinity chromatography
on amylose resin. The protein was used to generate the
standard curve.
Antibodies detection
Antibody screening was performed using a homemade
ELISA-antibody test. The serological ELISA test was de-
rived from a commercial assay exhibiting high specificity
and analytical sensitivity, namely 96.7 and 93.1%, re-
spectively [27]. The test was based on binding of anti-
Plasmodium antibodies present in serum or plasma
samples to antigens immobilized on 96-well plates, with
the antigen being an extract of in vitro P. falciparum
culture (3D7 strain). Due to antigenic community, anti-
bodies to other Plasmodium species may be detected.
The diluent solution containing PBS and Tween 0.1%,(125 μL) was poured into each well, followed by 25 μL of
test plasma. On the same plate, 25 μL positive control and
negative control were poured in single and triplicate wells,
respectively. The plate incubated for 60 min at 37°C before
being washed five times. One hundred μL of horseradish
peroxidase-conjugated rabbit anti-human IgG polyclonal
antibodies (Sigma-Aldrich, St Quentin, France) were
added to each well, and the plate incubated for a further
30 min at 37°C. The wells were washed five times, and 100
μL of TMB plus substrate solution (tetramethylbenzidine)
(Kem-en-tec, Denmark) were added to each well. The
plate was covered and incubated in the dark for 15 min at
37°C. Finally, 50 μL of 0.5 M sulphuric acid was added to
each well, and absorbance was read within 15 min at 450
nm, with a reference wave-length of 620 nm. Test valid-
ation required that the positive OD be >0.500 and the
negative OD≥0.200. The cut-off value was calculated by
multiplying the negative control wells’ average OD by four.
The antibody (Ab) index of each sample was calculated by
dividing its OD value by the cut-off value. The sample was
considered positive if the Ab index was >1.0, equivocal if
the Ab index was between 0.8 and 1.0, and negative if the
Ab index was ≤0.8. The test was not able to distinguish
between antibodies directed to either P. falciparum, P.
vivax, P. malariae, or P. ovale.
Data analysis
The data was analysed by the chi-squared, Bartlett's chi-
squared, and Kruskal-Wallis tests using Sigma Plot 2001
software (Sigma Plot 2001 Statistical Analysis Software,
San Jose, CA, USA) and Epi Info version 3.5.1. The re-
sults were expressed as mean ± standard deviation. Stat-





Among the 266 malaria patients, the antigen detection
test was able to detect 250 cases while missing 16,
resulting in a sensitivity of 94%, with borderline results
included as positive in the calculations. Nine cases of P.
falciparum were missed, five of them were treated for
malaria before the blood examination and the four
remaining patients did not provide any information’s re-
garding a previous treatment. Seven cases of P. ovale
were also missed may be due to the fact that the mono-
clonal antibodies for pLDH fail to detect some P. ovale
strains. However this point was not explored in our study
and not discussed. The antibody detection test was able to
detect only 220 cases (Table 1). Moreover, the combined
tests detected 261 positive cases and missed only five,
namely a P. falciparum-infected patient with prior anti-
malarial treatment, and four P. ovale-infected patients
Table 1 pLDH ELISA and Malaria antibody ELISA results
in a population of microscopically confirmed malaria
patients (n= 266)
Species Microscopy pLDH ELISA Antibody ELISA
P. falciparum 239/266 (89.9%) 230/239 199/239
P. ovale 19/266 (7.1%) 12/19 14/19
P. malariae 6/266 (2.25%) 6/6 5/6
Mixed infection1 2/266 (0.75%) 2/2 2/2
Total 250/266 (94%) 220/266 (82.7%)
1Mixed infections are P. ovale with P. falciparum.
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not-exposed-to-malaria blood donors was 99.6 and 99.5%,
respectively, with an overall specificity of 99.57%. The
pLDH assay’s positive and negative predictive values were
94.3% and 99.5%, respectively.Detectability
The parasite detection threshold for microscopy and
pLDH Elisa test was calculated using a range of infected
iRBCs and recombinant pLDH. The calculated parasit-
aemia in diluted iRBCs ranged from 24,676 iRBCs/μl to
0.0005,iRBCs/μl (extrapolated value), with a linear re-
gression line and 0.977 correlation coefficient. The de-
tection limit was 1 parasite/μL for the pLDH ELISA,
which corresponds to 0.08 ng/ml of recombinant pLDH.
The detection threshold with the standard curve using
the recombinant pLDH was 0.125 ng/mL, the curve be-
ing linear up to 2.5 ng/mL (Figure 1) (Table 3).pLDH assay evaluation in a population of Benin blood
donors
Characteristics of the blood donor population
Blood samples from 2,515 donors were collected over a
ten-month period covering four seasons: LRS, SDS, SRS,
and LDS. The samples were distributed as follows: 590/
2,515 (23.5%) in LRS, 409/2,515 (16.3%) in SDS, 630/
2,515 (25.0%) in SRS and 886/2,515 (35.2%) (Table 4).
The donors enrolled in this study were young, with a
median age of 31±9 years. Their age distribution showed
that young people between 25 and 40 years were the
most represented, with 1,379/2,515 (54.8%). SexTable 2 Comparison of pLDH ELISA (Ag) and antibody
ELISA (Ab) detection in a population of microscopically
confirmed malaria patients (n= 266)
Ab Pos Ab Neg Total
Ag pos 209 41 250
Ag neg 11 5* 16
TOTAL 220 46 266
*One case of P. falciparum infection treated prior to the parasitological
diagnosis and four P. ovale cases.distribution exhibited a strong male predominance with
2,027/2,515 (80.60%) men versus 488/2,515 (19.40%, 95%
CI: 17.9-21.0%) women. Among the donors, 1,989/2,515
slept under a mosquito net (79.1%, 95% CI: 77.4-80.6%).
The majority of donors, namely 1,521/2,515 (60.47%,
95% CI: 57.4-61.2%), reported having had episodes of
malaria, and the predominant clinical prior malaria ex-
pression was a single suspected access in 1,387/2,515
(55.1%, 95% CI: 53.2-57.1%), whereas 51 donors (2.0%,
95% CI: 1.5-2.7%) reported a severe attack requiring
hospitalization in the last year. In total, 83 donors (3.3%,
95% CI: 2.7-4.1) had both single and severe malaria at-
tacks, whereas 994 donors (39.52%) reported having no
malaria attack during the preceding year. Among the
1,521 donors with suspected malaria episodes, anti-
malarial treatment was administered to 509 (33.46%) in
health facilities during the last malaria attack, whereas
1,012/1,521 (66.53%) were treated as outpatients. Most
blood donors did not receive chemoprophylaxis but
performed a sort of prevention when they experienced
“signs of malaria”. Self-prevention against malaria was
undertaken by 1,537/2,515 donors (61.11%) who took
anti-malarial drugs or herbal tea, whereas 978/2,515
(38.88%) did not undertake any prevention. The drugs
used were quinine 567/2,515 (22.5%, 95% CI: 20.9-24.2%),
artemisinin-based combination 510/2,515 (20.3%, 95% CI:
18.7-21.9%), herbal teas 336/2,515 (13.4%, 95% CI: 12.1-
14.8%), and FansidarW 124/2,515 (4.9%, 95% CI: 4.1-5.9%).
Microscopic prevalence of Plasmodium
Among the 2,515 blood donors, the rate of asymptom-
atic Plasmodium carriage measured by microscopy was
295/2,515 (11.72%, 95% CI: 10.5-13.1%). Three Plasmo-
dium species were detected: P. falciparum was identified
in all infection cases, P. malariae in 14 mixed infection
cases (5.1%), and P. ovale in one mixed infection case
(0.34%) (Table 4). The study findings revealed a higher
percentage of infection among males 252/295 (85.42%)
compared to females 43/295 (14.6%). Microscopic preva-
lence varied according to seasons: P. falciparum and P.
malariae detection was constant during all seasons
(Table 4), whereas P. falciparum density was very low
and highly variable. Among the 295 positive donors, 238
(80.67%) exhibited a parasite density between seven and
100 parasites per microliter (p/μL), with 0.3% exhibiting
a density >5,000 p/μL (Table 5).
Malaria antibodies prevalence
Plasmodium antibody detection by ELISA in 2,515 do-
nors showed a high positivity rate with a prevalence of
73.9% (1,859/2,515) (95% CI: 72.1-75.6%). Equivocal re-
sults were found in 13.1% of samples (329/2,515), and
there were no detectable antibodies in 327 donors (13.0%,













Figure 1 pLDH detectability for Plasmodium falciparum and recombinant pLDH. Standard curve for a range of ten assays for rpLDH and 15
assays for Pf iRBCs. Detectability was 2.5 ng/mL for rpLDH and one parasite per μL for RBC.
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(Table 7 and Figure 2).
pLDH prevalence in Benin blood donors
pLDH antigen was found in 38.4% of blood donors
(966/2,515) (95% CI: 36.5-40.3%), with equivocal results
(n=622/2,515, 24.7%) considered as positive for thecalculation. The prevalence of pLDH antigen confirmed
by microscopy was 230/966 (23.8%). The only sample
that was positive by microscopy but negative by pLDH
detection was a P. malariae infection case, notably a
malaria-antibody positive sample (Table 6A).
pLDH antigen prevalence varied significantly ac-
cording to the season (P < 0.05) (Table 7 and Figure 2).
Table 3 Detectability of pLDH evaluated with a recombinant
pLDH (A) and Plasmodium falciparum-infected red blood
cells (Pf iRBCs) (B)
A






























Table 4 Distribution of microscopically detected Plasmodium
four seasons: long rainy season (LRS), short dry season (SDS)
Sampling period Positive/donors Positivity
rate
(N =2515) (%)
LRS (May-June-July) 67/590 11.4 P.
SDS (August -September) 48/409 11.7 P.
SRS (October-November) 100/630 16.0 P. fal
LDS (December-January-February) 80/886 9.0 P. f
TOTAL 295/2,515 11.72 P. falcip
*Mixed infection.
Table 5 Variation of parasitaemia in the 295 positive
donors by microscopy




> 5,000 1 0.3
Total 295
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equivocal pLDH index were microscopically negative.
However, a similar percentage was observed in micro-
scopically positive blood donors, suggesting that the grey
zone was correctly set up for pLDH (Table 8). The ab-
sence of antibodies in the blood of patients with detect-
able parasitaemia was noted in 30 cases (30/295; 10.2%),
but 20 of them tested positive when using the pLDH
ELISA. In 744/2,515 (29.6%) cases, both antibody and
antigen were present in samples, and 199 samples were
positive (n=112) or equivocal (n=87) for pLDH and nega-
tive for antibodies (Table 9).
Discussion
In this study, a commercialized pan Plasmodium LDH
ELISA was shown to exhibit optimal performances as to
both PPV and NPV. The assay was able to detect one
parasite per μL, which is the lowest detectability
reported in the scientific literature to date. This detec-
tion threshold is much lower than that of the already
commercialized rapid test [28], which is estimated at 50
parasites/μL. An ELISA-based assay would theoretically
lower that detectability. Indeed, another ELISA assay
based on HRP2 detection was able to detect 11.7 para-
sites/μL, which is equivalent to 6 ng/ml of rPfHRP2 [29].
The authors of this study conducted in Kenya reported
that the microscopic detection limit was three parasites/
μL, with a lower reproducibility. The ELISA assay, which
is able to detect in vitro lower amounts of P. falciparum
and other species, would thus be an interesting tool to
detect the presence of Plasmodium in a given bloodspecies in a population of 2,515 blood donors during the
, short rainy season (SRS), and long dry season (LDS)
Prevalence species
(N= 295)
falciparum (64/67) 95.52%; *P. malariae (3/67) 4.47%; P. ovale (0) 0.0%
falciparum (45/48) 93.75%; *P. malariae (3/48) 6.25%; P. ovale (0) 0.0%
ciparum (96/100) 96.0%; *P. malariae (3/100) 3.0%; *P. ovale (1/100) 1.0%
alciparum (75/79 (93.75%; *P. malariae (5/80) 6.25%; P. ovale (0) 0.00%
arum (280/295) 95.0%; *P. malariae (14/295) 5.0%; *P. ovale (1/295) 0.34%
Mixed infection (15/295) 5.10%
Table 6 Comparison of microscopy with pLDH ELISA (A)
and antibody ELISA (B) in blood donors
A pLDH ELISA
Positive Equivocal Negative TOTAL
Positive 230 64 1 295
Microscopy Negative 736 558 926 2,220
TOTAL 966 622 927 2,515
B Antibody ELISA
Positive Equivocal Negative TOTAL
Positive 231 34 30 295
Microscopy Negative 1,628 295 297 2,220
TOTAL 1,859 329 327 2,515
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seven cases of P. ovale out of 19 cases. This defect could
due to the incapability of the assay to detect the pLDH
from some strains of P. ovale [30]. The use of a commer-
cialized pan Plasmodium LDH ELISA was evaluated in a
large blood donor population from southern Benin. The
test results were compared to those obtained using mi-
croscopy and to those pertaining to malaria-antibody
prevalence. The study aimed to determine whether pLDH
detection was sensitive enough to identify low parasit-
aemia levels, which are frequently the case in asymptom-
atic malaria blood donors, and to assess the prevalence of
positive pLDH blood donations in southern Benin.
This study enrolled 2,515 blood donors from six
southern Benin departments, with similar malaria epi-
demiological features. These departments exhibit a wet
tropical climate, with two rainy seasons and two dry sea-
sons. In these regions, malaria transmission is perman-
ent, with an increase during the rainy season [16]. The
most transmitted species are P. falciparum (97.10%) and
P. malariae (2.00%) [15,31]. The figures reported in the
literature are similar to those found in this study, with a
95.0% prevalence of P. falciparum and 4.7% prevalence
of P. malariae. The overall prevalence of asymptomatic
Plasmodium carriage here was 11.72%. Plasmodium fal-
ciparum parasite density proved to be very low and
highly variable. Two-third of these positive donors had a
parasite density between seven and 100 parasites per μL.
Reported prevalence rates in Benin appear to be similar
to those reported by some authors in neighbouring
Nigeria, 10.2% [32], or in Ghana, 10.20%. [33]. In thisTable 7 Positivity rate of pLDH ELISA and antibody ELISA tes
the seasons, long rainy season (LRS), short dry season (SDS),
LRS SDS
pLDH ELISA POS 142 (24.1%) 206 (50.3
Antibody ELISA POS 453 (76.7%) 288 (70.1study, P. falciparum was identified in all infected cases,
5.0% of which were mixed P. malariae infections. These
figures are in line with the reported presence of P. fal-
ciparum in all infected cases and the 2.3% rate of mixed
infection in Nigeria [3]. However, these results differ
from those of other authors who reported higher para-
site prevalence rates, namely 50.7% in Burkina Faso [34],
55% in Nigeria [13,23], and 33.52% in Benin [4].
The study findings highlighted a higher infection rate in
male blood donors compared to female ones (85.42 vs
14.6%). In a study conducted in Colombia [35], males were
also found to be more infected with Plasmodium ssp. than
females, 59 and 41%, respectively. Nevertheless, in a 1994
publication by Vlassoff et al. [36], Ghanaian women were
found to have higher infection rates than Ghanaian men.
According to the study, the risk of Plasmodium trans-
mission through blood transfusion is accounted for by
the persistence of malaria parasites in blood. Canonical
knowledge indicates that P. falciparum may persist in
blood for one year, P. ovale for three years, and P.
malariae for even longer time periods before causing
malaria [20,32]. Similarly, the fact that malarial parasites
may survive in RBCs at refrigerator temperatures (2-6°C)
for days or weeks leads to the original exclusion of all
blood donors who could represent a potential risk in
TTM [6,7]. This observation supports some authors’ sug-
gestions, namely to implement Plasmodium screening
prior to blood donation in Africa [3,37].
In non-malaria-endemic area, the malaria antibody de-
tection test will result in rejecting blood donation in case
of positivity. However, in malaria-endemic countries,
such as Benin, this tool is useless. Indeed, malaria anti-
body prevalence was 87% (74.0% positive and 13%
equivocal) in the study’s blood donor populations. This
prevalence was similar to that reported for Senegal, with
65.33% being positive and 6.86% equivocal [19]. Therefore,
this high antibody seroprevalence in blood donors invali-
dates the marker’s use for detecting Plasmodium-infected
blood donations. It is interesting to note that detectable
Plasmodium parasites were found in blood donors but
without antibodies, suggesting an acute infection.
In this study, 38.4% of the blood donors were tested
positive for pLDH antigen, with a 4.2% rate of equivocal
results. The pLDH antigen detection results differed from
those found by Diop et al. in Senegal, who reported a de-
tection rate of 0.53% for pLDH, with a 2.23% rate ofts according to infecting donors by Plasmodium during
short rainy season (SRS), and long dry season (LDS)
Season
SRS LDS TOTAL
%) 323 (51.3%) 295 (33.3%) 966 (38.4%)











































Figure 2 Prevalence rates were calculated for Plasmodium
presence by microscopy and pLDH detection, and for malaria
antibodies in a population of asymptomatic blood donors
(n= 2,515) over a ten-month period, divided in long rainy season
(LRS) from May to July 590/2,515, short dry season (SDS) from
August to September 409/2,515, short rainy season (SRS) from
October to November 100/630, and long dry season (LDS)
from December to February 80/886.
Table 9 Antibody ELISA and pLDH ELISA comparative
results for Benin blood donors
pLDH ELISA
Positive Equivocal Negative Total
Antibody ELISA Positive 744 442 673 1,859
Equivocal 110 94 126 329
Negative 112 87 128 327
TOTAL 966 622 927 2,515
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http://www.malariajournal.com/content/12/1/279doubtful cases [19]. However, the malaria epidemiology in
Senegal is highly different from that in Benin. The low
parasitaemia level may escape microscopic examination,
while being dependent on the reader’s skill. The pLDH
ELISA exhibited a detectability threshold lower than that
of the other methods, with the exception of PCR. This
finding suggests that pLDH detection could be a valid
tool for blood bank settings in order to identify blood
donation with a detectable parasitic load of at least one
parasite per μL.
The questionnaire’s effectiveness helped to identify cer-
tain risk factors associated with pLDH antigen carriage,
such as blood donations during high transmission periods.
Based on the study results it was noticed that seasons
influenced both microscopic and pLDH prevalence.
Others factors likely impact these markers, such as the
malaria prevention method used by blood donors, i.e.
drugs, herbal teas, etc. The limits of selecting bloodTable 8 Distribution of pLDH ELISA in microscopically
positive and negative blood donors
pLDH ELISA
index
Positive donors Negative donors
Frequency Percent (%) Frequency Percent (%)
>20 45 15.3 2 0.01
10-20 24 8.1 2 0.01
1-10 161 54.6 737 33.2
0.7-0.99 64 21.7 558 25.1
Negative 1 0.3 921 41.5
TOTAL 295 2,220donors through medical questionnaires were highlighted
by the study findings, as 38.4% positive donors for ELISA
pLDH had met the selection criteria and gave their blood.
It is, therefore, logical to propose implementation of Plas-
modium screening in blood donation, which was not
performed in Benin due to costs and lack of technique reli-
ability, still keeping in mind that blood donors who report
an undiagnosed and untreated febrile illness consistent
with malaria should be deferred until asymptomatic and
off the treatment. In a recent cost effectiveness analysis
study, Rajab et al. [38] concluded that pretransfusion
screening would be less costly than the recommended
artemisinin-based combination used for prophylaxis in
blood recipients, especially children and pregnant women.
Conclusion
Malaria and transfusion is a “neglected subject coming
back to the fore front”, as recently discussed by Allain
[39]. The microscopy and antibody detection techniques
are not suited for mass screening in a blood transfusion
centre in endemic areas. Based on this study results, the
pLDH antigen detection ELISA for Plasmodium could
be an interesting tool for blood donation qualification in
order to ensure blood safety in malaria-endemic areas.
One of the test’s advantages is that false-positives are ex-
ceptional, unlike the HRP2 (histidine-rich-protein)-based
tests, which can remain positive for two weeks after
parasite clearance. HRP2 may also be absent in malaria
infection cases. pLDH antigen ELISA detection in the
blood is efficient when there is a parasite [40]. Some pit-
falls were observed in the study. In some P. ovale infec-
tion cases the assay failed to detect them. Similarly, if
the donors had taken self-treatment measures prior to
blood donation, malaria infection was masked and
pLDH detection failed. In conclusion, routine screening
of all donated blood would prevent infected blood dona-
tion and increase the donation’s safety for fragile recipi-
ents, such as children and pregnant women. It would
also be instrumental in reducing unnecessary medical
treatments in recipients and contribute to lower Plasmo-
dium resistance. The main problem remains the feasibil-
ity of rejecting positive donations in term of blood
availability in endemic area where blood transfusion needs
are presently increasing.
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